Research, Select, & Monitor Sunday, October 25, 2020 6:57:13 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Incyte Corp.$89.69($.80)(.88%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Incyte to Report Second Quarter Financial Results
   Thursday, July 16, 2020 8:00:00 AM ET

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, August 4, 2020.

The schedule for the press release and conference call/webcast is as follows:

  • Q2 2020 Press Release:

August 4, 2020 at 7:00 a.m. ET

  • Q2 2020 Conference Call:

August 4, 2020 at 8:00 a.m. ET

  • Domestic Dial-In Number:


  • International Dial-In Number:


  • Conference ID Number:


If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13706620.

The live webcast with slides can be accessed at and will be available for replay for 90 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte .

Incyte Contacts
Catalina Loveman
+1 302 498 6171

Michael Booth, DPhil
+1 302 498 5914

Source: Incyte

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.